Key takeaways
MarketScan remains the evidence anchor. Its longitudinal closed-claims data support trusted real-world research at scale, with a foundation spanning 300M+ patients.
The MarketScan Partner Ecosystem adds depth. Curated datasets help extend MarketScan analyses beyond claims alone.
Lab and diagnostic results add clinical context. De-identified lab results can help connect objective clinical measures with patient journeys.
Linked data can sharpen real-world evidence. Claims plus lab results can support more precise studies of treatment patterns, severity, outcomes, and resource use.
Real-world evidence is most powerful when it reflects the complexity of real patient journeys. Claims data can show how patients move through the healthcare system, which treatments they receive, what services they use, and how costs accumulate over time. But many research questions require additional clinical depth, such as laboratory values, biomarkers, test results, or facility-level detail.
That need is exactly what the MarketScan Partner Ecosystem was designed to address. Launched in May, the ecosystem enables organizations to link MarketScan® Research Databases with curated, fit-for-purpose datasets from trusted collaborators. The initial launch introduced expanded evidence options such as hospital chargemaster data from FinThrive® and existing electronic health record collaborator data, helping clients move beyond closed claims while maintaining the rigor and consistency MarketScan is known for.
Now, the ecosystem is expanding again with a new collaboration that brings de-identified laboratory and diagnostic results into the MarketScan evidence environment. For life sciences, diagnostics, and health research teams, this means more ways to connect objective clinical measures with longitudinal claims history to generate richer, more precise real-world evidence.
MarketScan is among the most comprehensive longitudinal closed-claims datasets in the industry, capturing healthcare utilization and costs across large, diverse U.S. populations. For decades, researchers have used MarketScan data to study disease burden, treatment patterns, outcomes, and healthcare economics across a wide range of therapeutic areas.
The Partner Ecosystem builds on that foundation by making it easier to add the most relevant data elements for a specific research question. Instead of relying on one dataset to answer every question, organizations can enrich MarketScan analyses with complementary datasets that add clinical, facility-level, diagnostic, or patient-level context.
Hospital chargemaster data can add detailed facility-level information, such as inpatient drug and medical device utilization and granular cost detail.
EHR collaborator data can help add clinical depth from ambulatory and specialty care settings.
Laboratory and diagnostic results can help researchers better understand disease severity, treatment response, and clinical outcomes over time.
Laboratory and diagnostic results can add objective clinical measures that claims alone may not fully capture, such as viral loads, biomarker levels, genetic test results, or other test values. When linked to MarketScan claims data, lab results can help researchers identify clinically meaningful subgroups, evaluate disease activity, and observe how changes in lab values align with treatment patterns, healthcare resource use, and outcomes.
For example, lab-linked evidence may help researchers examine how baseline inflammation levels affect outcomes in autoimmune diseases, how biomarker changes relate to treatment response, or how diagnostic results correspond with patient journeys across care settings. This added clinical context can support more nuanced health economics and outcomes research, evidence planning, and drug or diagnostic development.
By bringing this lab data into the MarketScan Partner Ecosystem, Truven is expanding the types of research questions clients can address while keeping MarketScan as the consistent claims-based anchor for evidence generation.
This latest collaboration is not just an incremental data addition. It reflects the broader purpose of the MarketScan Partner Ecosystem: to give organizations more flexibility to build evidence strategies around the data elements that matter most for their research questions.
As healthcare research questions become more specific and multidimensional, organizations need evidence generation approaches that can connect claims, clinical, diagnostic, facility-level, and other real-world data sources in a rigorous way. By expanding MarketScan with partner datasets such as lab results and FinThrive hospital chargemaster data, MarketScan is helping researchers move from “what happened” toward a more complete view of why it happened, for whom, and with what impact.
Ready to learn more about how the MarketScan Partner Ecosystem can support real-world evidence generation? Connect with our team today.